Benitec Biopharma Inc.
BNTCCIK 0001808898 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Mar 20, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0131
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Benitec Biopharma Inc.
| Name | Roles | Filings |
|---|---|---|
| Boston Megan | OfficerDirector | 5 |
| Banks Jerel A. | OfficerDirector | 4 |
| Francis Peter | Director | 3 |
| Mates Sharon | Director | 3 |
| Smith Edward F | Director | 3 |
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Benitec Biopharma Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Averill Madison Master Fund, Ltd. | 30 | 47% | +0.6% | 0.0% | +27.6% | -25.4% |
| 2 | Averill Master Fund, Ltd. | 30 | 47% | +0.6% | 0.0% | +27.6% | -25.4% |
| 3 | Cowen Aaron | 30 | 47% | +0.6% | 0.0% | +27.6% | -25.4% |
| 4 | Suvretta Capital Management, LLC | 30 | 47% | +0.6% | 0.0% | +27.6% | -25.4% |
All filings
37 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|